Totect (Cumberland Pharmaceuticals Inc.)
Welcome to the PulseAid listing for the Totect drug offered from Cumberland Pharmaceuticals Inc.. This Cytoprotective Agent [EPC] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: | Cumberland Pharmaceuticals Inc. |
NON-PROPRIETARY NAME: | dexrazoxane hydrochloride |
SUBSTANCE NAME: | DEXRAZOXANE HYDROCHLORIDE |
TYPE: | HUMAN PRESCRIPTION DRUG |
PHARMA CLASS: | Cytoprotective Agent [EPC] |
ROUTE: | INTRAVENOUS |
DOSAGE FORM: | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION |
MARKETING CATEGORY NAME: | NDA |
START MARKETING DATE: | 2017-07-25 |
END MARKETING DATE: | 0000-00-00 |
Totect HUMAN PRESCRIPTION DRUG Details:
Item Description | Totect from Cumberland Pharmaceuticals Inc. |
LABELER NAME: | Cumberland Pharmaceuticals Inc. |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 500(mg/1) |
START MARKETING DATE: | 2017-07-25 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 66220-110_25c418f4-00b5-471c-9473-e84fa740c4ea |
PRODUCT NDC: | 66220-110 |
APPLICATION NUMBER: | NDA022025 |
Other DEXRAZOXANE HYDROCHLORIDE Pharmaceutical Manufacturers / Labelers: